164 related articles for article (PubMed ID: 10021451)
1. Novel pharmacologic therapies for cystic fibrosis.
Zeitlin PL
J Clin Invest; 1999 Feb; 103(4):447-52. PubMed ID: 10021451
[No Abstract] [Full Text] [Related]
2. Drug bests cystic-fibrosis mutation.
Ledford H
Nature; 2012 Feb; 482(7384):145. PubMed ID: 22318583
[No Abstract] [Full Text] [Related]
3. Pharmacologic approaches to correcting the basic defect in cystic fibrosis.
Lukacs GL; Durie PR
N Engl J Med; 2003 Oct; 349(15):1401-4. PubMed ID: 14534332
[No Abstract] [Full Text] [Related]
4. Rescuing protein conformation: prospects for pharmacological therapy in cystic fibrosis.
Gelman MS; Kopito RR
J Clin Invest; 2002 Dec; 110(11):1591-7. PubMed ID: 12464661
[No Abstract] [Full Text] [Related]
5. [Modifier genes and cystic fibrosis].
Corvol H; Flamant C; Vallet C; Clement A; Brouard J
Arch Pediatr; 2006 Jan; 13(1):57-63. PubMed ID: 16274977
[TBL] [Abstract][Full Text] [Related]
6. A novel nonsense mutation, S466Xa in exon 10 of the cystic fibrosis transmembrane conductance regulator gene.
Mittre H; Barre M; Leymarie P
Hum Mutat; 1996; 8(4):392-3. PubMed ID: 8956053
[No Abstract] [Full Text] [Related]
7. Homozygosity for L997F in a child with normal clinical and chloride secretory phenotype provides evidence that this cystic fibrosis transmembrane conductance regulator mutation does not cause cystic fibrosis.
Derichs N; Schuster A; Grund I; Ernsting A; Stolpe C; Körtge-Jung S; Gallati S; Stuhrmann M; Kozlowski P; Ballmann M
Clin Genet; 2005 Jun; 67(6):529-31. PubMed ID: 15857421
[No Abstract] [Full Text] [Related]
8. A new frameshift mutation 460delG in exon 4 of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
Wagner K; Schneditz P; Rosenkranz W
Hum Mutat; 1996; 7(2):183. PubMed ID: 8829644
[No Abstract] [Full Text] [Related]
9. Novel de novo large deletion in cystic fibrosis transmembrane conductance regulator gene results in a severe cystic fibrosis phenotype.
Norek A; Stremska M; Sobczyńska-Tomaszewska A; Wertheim-Tysarowska K; Dmeńska H; Jurek M
J Pediatr; 2011 Aug; 159(2):343-6.e1. PubMed ID: 21663921
[TBL] [Abstract][Full Text] [Related]
10. Sweat chloride concentration in cystic fibrosis patients with cystic fibrosis trans-membrane conductance regulator 11234V mutation.
Al-Mendalawi MD; Abdul-Wahab A; Janahi IA; Abdel-Rahman MO
Saudi Med J; 2010 Mar; 31(3):339-40; author reply 340. PubMed ID: 20231949
[No Abstract] [Full Text] [Related]
11. Identification of four novel mutations in the cystic fibrosis transmembrane conductance regulator gene: E664X, 2113delA, 306delTAGA, and delta M1140.
Clavel C; Pennaforte F; Pigeon F; Verlingue C; Birembaut P; Férec C
Hum Mutat; 1997; 9(4):368-9. PubMed ID: 9101301
[No Abstract] [Full Text] [Related]
12. What is cystic fibrosis?
Knowles MR; Durie PR
N Engl J Med; 2002 Aug; 347(6):439-42. PubMed ID: 12167688
[No Abstract] [Full Text] [Related]
13. Identification of a novel mutation, 1087delT, in exon 7 of the CFTR gene in a patient with cystic fibrosis.
Feuillet-Fieux MN; Sermet I; Edelman A; Torossi T; Ferrec M; Guillot M; Lenoir G; Bonnefont JP; Thuillier L
Hum Mutat; 2000 Jul; 16(1):95. PubMed ID: 10874326
[No Abstract] [Full Text] [Related]
14. Sweat chloride concentration in cystic fibrosis patients with cystic fibrosis trans-membrane conductance regulator I1234V mutation.
Abdul-Wahab A; Janahi IA; Abdel-Rahman MO
Saudi Med J; 2009 Aug; 30(8):1101-2. PubMed ID: 19668897
[No Abstract] [Full Text] [Related]
15. A mouse model for the delta F508 allele of cystic fibrosis.
Zeiher BG; Eichwald E; Zabner J; Smith JJ; Puga AP; McCray PB; Capecchi MR; Welsh MJ; Thomas KR
J Clin Invest; 1995 Oct; 96(4):2051-64. PubMed ID: 7560099
[TBL] [Abstract][Full Text] [Related]
16. [Protein repair therapy in cystic fibrosis].
Clément A; Tamalet A; Fauroux B; Epaud R
Rev Prat; 2003 Jan; 53(2):163-6. PubMed ID: 12664848
[TBL] [Abstract][Full Text] [Related]
17. Combating cystic fibrosis: in search for CF transmembrane conductance regulator (CFTR) modulators.
Noy E; Senderowitz H
ChemMedChem; 2011 Feb; 6(2):243-51. PubMed ID: 21275046
[No Abstract] [Full Text] [Related]
18. Variant cystic fibrosis phenotypes in the absence of CFTR mutations.
Couper RT
N Engl J Med; 2002 Dec; 347(23):1892-3; author reply 1892-3. PubMed ID: 12466520
[No Abstract] [Full Text] [Related]
19. [Cystic fibrosis in a woman aged seventy].
Ras JE; van Velzen E; van Berkhout FT; van den Brand JJ
Ned Tijdschr Geneeskd; 2010; 154():A1342. PubMed ID: 20619026
[TBL] [Abstract][Full Text] [Related]
20. [Cystic fibrosis transmembrane conductance regulator (CFTR) gene: mutations and clinical phenotypes].
Schwartz M
Ugeskr Laeger; 2003 Feb; 165(9):912-6. PubMed ID: 12661515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
